anti inflammatory effects of glp 1 GLP-1 receptor agonists—another promising therapy for Alport syndrome? | Journal Rare Diseases GLP-1 receptor agonists as promising
Description
Novo Nordisk offers a sample letter that some healthcare providers use as a template
[Google Scholar] 90
Patients should use only FDA-approved drugs from licensed pharmacies and consult their healthcare provider with any concerns
M.SaydahS.ImperatoreG.GreggE
Biomedicine & Pharmacotherapy, 169 , 115858
